Weil Patent Litigation and Life Sciences practices Co-Head Edward Reines has been recognized as a Life Sciences “Trailblazer” by The National Law Journal. In a special supplement to NLJ, he was profiled among a select group of 26 attorneys recognized as “agents of change” in their respective practice areas.

The profile noted that Mr. Reines, one of the country’s foremost patent litigators, has deep ties to Silicon Valley and has worked closely with many of its technology pioneers. He has particular expertise in the field of genomics and has helped safeguard patents for breakthrough technologies in the field, going back to the first successful efforts to map the human genome.

The article highlighted Mr. Reines’ record of success defending cutting-edge IP and market share for leaders in genomic medicine. Over the course of his 30-year career, Mr. Reines has secured numerous high-profile victories, including landmarks in the field. His recent accomplishments include representing for Bio-Rad Laboratories and University of Chicago in a $20+ million patent infringement suit brought against competitor 10X Genomics, which culminated in July 2019 with a post-trial permanent injunction barring 10X from manufacturing or selling a number of infringing genetic testing products.

The article also cited Mr. Reines’ success representing Illumina and Verinata Health in a high-stakes patent battle with Ariosa Diagnostics regarding a revolutionary non-invasive prenatal genetic test. He was also credited for defending California Institute of Technology researchers against allegations that they were not the original named inventors of modern DNA sequencing.

Mr. Reines noted his work in the emerging field of “precision medicine,” which is focused on disease treatment and prevention through variability in genes.

“Genomics is at its dawn,” Mr. Reines told NLJ. “And where we’ve been entrusted, we hope to do our part to assist these innovators.”

Mr. Reines was previously named an NLJ Intellectual Property “Trailblazer” in 2018. He is the 17th Weil partner since late 2015 to be named a “Trailblazer” in his or her respective field of expertise.